An individual-patient meta-analysis sheds light on the optimal duration of androgen deprivation therapy in men with prostate cancer on definitive radiotherapy.
1don MSN
Israeli hospital's groundbreaking studies could lessen treatments, reduce prostate cancer risks
A groundbreaking study at Rabin Medical Center suggests prostate cancer patients may need only two radiation doses, ...
Around 55,000 new cases of prostate cancer are diagnosed in the UK every year, and super drug abiraterone will offer hope to ...
Abiraterone will be available in a matter of weeks and will be offered to 7,000 men a year.
14don MSN
Easy-to-use tool can identify high- and low-risk metastatic prostate cancer patients earlier
A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment ...
To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...
Thousands of men battling prostate cancer are set to gain access to a life-extending drug on the NHS following a significant ...
University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...
A novel long-term prediction model showed promise at estimating the risk for dying of prostate cancer, an analysis published ...
The decision means Northern Ireland remains the only country in the UK where patients with this stage of prostate cancer are ...
The Alabama Senate Thursday approved a bill that would require health insurance companies to cover prostate cancer screenings ...
As soon as the urologist said, oh it’s cancer…that is an eye-opener,” says Mark Stiegler, reflecting on his diagnosis six ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results